These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 2071979

  • 21. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP, Shrikhande SN, Kulkarni SW, Maldhure BR.
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [Abstract] [Full Text] [Related]

  • 22. Prospective immunological follow-up in household contacts of Mexican leprosy patients.
    Amezcua ME, Escobar-Gutiérrez A, Barba-Rubio J, Cázares JV, Mayén E, Chávez-Núñez M, Peña RC, Rodríguez R, Pastén S.
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):651-9. PubMed ID: 2280115
    [Abstract] [Full Text] [Related]

  • 23. Double jeopardy: women and leprosy in India.
    Vlassoff C, Khot S, Rao S.
    World Health Stat Q; 1996 Dec; 49(2):120-6. PubMed ID: 9050190
    [Abstract] [Full Text] [Related]

  • 24. Incidence rates of leprosy among household contacts of "primary cases".
    Jesudasan K, Bradley D, Smith PG, Christian M.
    Indian J Lepr; 1984 Dec; 56(3):600-14. PubMed ID: 6549329
    [Abstract] [Full Text] [Related]

  • 25. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glodé MP, Ehresmann KR, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kbisgard@cdc.gov.
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [Abstract] [Full Text] [Related]

  • 26. Indeterminate leprosy in a population survey and in the subsequent follow-ups of children in Burma.
    Bechelli LM.
    Acta Leprol; 1989 Aug; 7(1):29-36. PubMed ID: 2533781
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of childhood pulmonary tuberculosis: a case control study in Nagpur, India.
    Zodpey SP, Shrikhande SN, Maldhure BR, Vasudeo ND, Kulkarni SW.
    Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):285-8. PubMed ID: 9886114
    [Abstract] [Full Text] [Related]

  • 28. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years.
    Sharma P, Mukherjee R, Talwar GP, Sarathchandra KG, Walia R, Parida SK, Pandey RM, Rani R, Kar H, Mukherjee A, Katoch K, Benara SK, Singh T, Singh P.
    Lepr Rev; 2005 Jun; 76(2):127-43. PubMed ID: 16038246
    [Abstract] [Full Text] [Related]

  • 29. Current profile of active leprosy in Greece; a five-year retrospective study (1988-1992).
    Kyriakis KP, Kontochristopoulos GJ, Panteleos DN.
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):547-51. PubMed ID: 7868952
    [Abstract] [Full Text] [Related]

  • 30. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP, Ogbeiwi OI.
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [Abstract] [Full Text] [Related]

  • 31. Comparative leprosy vaccine trial in south India.
    Gupte MD, Vallishayee RS, Anantharaman DS, Nagaraju B, Sreevatsa, Balasubramanyam S, de Britto RL, Elango N, Uthayakumaran N, Mahalingam VN, Lourdusamy G, Ramalingam A, Kannan S, Arokiasamy J.
    Indian J Lepr; 1998 Jun; 70(4):369-88. PubMed ID: 10189587
    [Abstract] [Full Text] [Related]

  • 32. A case-control study of maternal knowledge of malnutrition and health-care-seeking attitudes in rural South India.
    Saito K, Korzenik JR, Jekel JF, Bhattacharji S.
    Yale J Biol Med; 1997 Jun; 70(2):149-60. PubMed ID: 9493847
    [Abstract] [Full Text] [Related]

  • 33. Long lasting BCG protection against leprosy.
    Rodrigues LC, Kerr-Pontes LR, Frietas MV, Barreto ML.
    Vaccine; 2007 Sep 28; 25(39-40):6842-4. PubMed ID: 17728023
    [Abstract] [Full Text] [Related]

  • 34. Leprosy survey in industries in Bombay.
    Revankar CR, Gupta V, Deshpande SS, Pai R, Ganapati R.
    Indian J Lepr; 1989 Jul 28; 61(3):367-72. PubMed ID: 2768884
    [Abstract] [Full Text] [Related]

  • 35. BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma.
    Bechelli LM, Garbajosa PG, Gyi MM, Uemura K, Sundaresan T, Martínez Domínguez V, Matejka M, Tamondong C, Quagliato R, Engler V, Altmann M.
    Bull World Health Organ; 1973 Jul 28; 48(3):323-34. PubMed ID: 4270384
    [Abstract] [Full Text] [Related]

  • 36. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T, Kaur I, Kumar B, Radotra BD, Dogra S.
    Int J Lepr Other Mycobact Dis; 2005 Jun 28; 73(2):105-14. PubMed ID: 16830653
    [Abstract] [Full Text] [Related]

  • 37. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79.
    Bagshawe A, Scott GC, Russell DA, Wigley SC, Merianos A, Berry G.
    Bull World Health Organ; 1989 Jun 28; 67(4):389-99. PubMed ID: 2680140
    [Abstract] [Full Text] [Related]

  • 38. Tuberculosis prevention: where do we go from here?
    Warndorff DK.
    Afr Health; 1996 Nov 28; 19(1):21-2. PubMed ID: 12291917
    [Abstract] [Full Text] [Related]

  • 39. Role of paucibacillary leprosy in the transmission of disease.
    Halder A, Mundle M, Bhadra UK, Saha B.
    Indian J Lepr; 2001 Nov 28; 73(1):11-5. PubMed ID: 11326593
    [Abstract] [Full Text] [Related]

  • 40. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP.
    Indian J Public Health; 2004 Nov 28; 48(2):70-7. PubMed ID: 15709589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.